In first interview as FDA oncology chief, Angelo de Claro vows to ‘continue the innovation’ behind OCE legacy

In his first interview after taking the reins of the FDA’s Oncology Center of Excellence, Angelo de Claro, M.D., is outlining a regulatory agenda that prioritizes organizational strength and continued regulatory modernization.